Kanmura Y, Kajikuri J, Itoh T, Yoshitake J
Department of Anesthesiology and Critical Care Medicine, Faculty of Medicine, Kyushu University, Fukuoka, Japan.
Anesthesiology. 1993 Sep;79(3):571-9. doi: 10.1097/00000542-199309000-00022.
Ketamine acts directly on vascular smooth muscle, causing relaxation. It has been suggested that the mechanism underlying this action involves an interference with transmembrane Ca2+ influx and an inhibition of Ca2+ release from intracellular Ca2+ stores. In vascular smooth muscle cells, agonist-induced Ca2+ release is thought to be mediated by an intracellular second messenger, inositol 1,4,5-trisphosphate (InsP3). To investigate the site at which ketamine acts on agonist-induced contraction, the authors studied the effects of ketamine on contraction and on the synthesis of InsP3 in smooth muscles of the rabbit mesenteric artery.
Changes in isometric tension of smooth muscle fibers were measured by attaching a thin circular strip from the rabbit mesenteric artery to a strain gauge. To measure the norepinephrine (NE)-induced production of InsP3, smooth muscle strips of the rabbit mesenteric artery were exposed to the agents and homogenized. Inositol 1,4,5-trisphosphate in the supernatant fractions was then assayed.
Ketamine dose-dependently inhibited contractions induced by high K+, NE, and histamine in normal Krebs solution. Ketamine also inhibited the NE- or histamine-induced contraction in Ca(2+)-free solution containing 2 mM ethylene-glycol bis-(beta-aminoethylether)-N,N,N',N'-tetraacetic acid (EGTA), indicating that this drug inhibits agonist-induced Ca2+ release from intracellular stores. Norepinephrine (10 microM) transiently increased the synthesis of InsP3 in Ca(2+)-free solution, and ketamine (0.1-1.0 mM) inhibited this effect, in a dose-dependent manner.
These results indicate that, in the rabbit mesenteric artery, ketamine inhibits agonist-induced Ca2+ release through its inhibitory action on the agonist-induced synthesis of InsP3. Thus, it is possible that ketamine interferes with the synthesis of intracellular second messengers.
氯胺酮直接作用于血管平滑肌,引起舒张。有人提出,这一作用的潜在机制涉及干扰跨膜Ca2+内流以及抑制细胞内Ca2+储存库释放Ca2+。在血管平滑肌细胞中,激动剂诱导的Ca2+释放被认为是由细胞内第二信使肌醇1,4,5-三磷酸(InsP3)介导的。为了研究氯胺酮作用于激动剂诱导收缩的位点,作者研究了氯胺酮对兔肠系膜动脉平滑肌收缩及InsP3合成的影响。
通过将兔肠系膜动脉的薄环形条带连接到应变仪上,测量平滑肌纤维等长张力的变化。为了测量去甲肾上腺素(NE)诱导的InsP3生成,将兔肠系膜动脉的平滑肌条带暴露于相应试剂并匀浆。然后测定上清液中的肌醇1,4,5-三磷酸。
在正常Krebs溶液中,氯胺酮剂量依赖性地抑制高K+、NE和组胺诱导的收缩。氯胺酮还抑制含2 mM乙二醇双(β-氨基乙醚)-N,N,N',N'-四乙酸(EGTA)的无Ca2+溶液中NE或组胺诱导的收缩,表明该药物抑制激动剂诱导的细胞内储存库释放Ca2+。去甲肾上腺素(10 μM)在无Ca2+溶液中短暂增加InsP3的合成,氯胺酮(0.1 - 1.0 mM)以剂量依赖性方式抑制此效应。
这些结果表明,在兔肠系膜动脉中,氯胺酮通过对激动剂诱导的InsP3合成的抑制作用,抑制激动剂诱导的Ca2+释放。因此,氯胺酮有可能干扰细胞内第二信使的合成。